Interferon-gamma release assays for diagnosis of latent TB infection in chronic kidney diseases and dialysis patients

INTRODUCTION: Patients with chronic kidney disease (CKD), especially end-stage kidney disease (ESKD), are at risk of developing tuberculosis (TB). The prevalence and predictors of LTBI assessed by a high-sensitivity, high-specificity test such as an interferon-gamma release assay (IGRA) has not been...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayuk, Pattorn, Boongird, Sarinya, Pornsuriyasak, Prapaporn, Bruminhent, Jackrapong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701719/
https://www.ncbi.nlm.nih.gov/pubmed/36452296
http://dx.doi.org/10.3389/fcimb.2022.1046373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701719/
https://www.ncbi.nlm.nih.gov/pubmed/36452296
http://dx.doi.org/10.3389/fcimb.2022.1046373

Ejemplares similares